Zymeworks
(NASDAQ) ZYME
Zymeworks Financials at a Glance
Market Cap
$1.80B
Revenue (TTM)
$105.97M
Net Income (TTM)
$81.13M
EPS (TTM)
$-1.08
P/E Ratio
-22.41
Dividend
$0.00
Beta (Volatility)
0.97 (Low)
Dividend
$0.00
Beta (Volatility)
0.97 (Low)
Price
$24.21
Volume
204
Open
$24.63
Price
$24.21
Volume
204
Open
$24.63
Previous Close
$24.21
Daily Range
$23.91 - $24.81
52-Week Range
$9.03 - $28.49
Dividend
$0.00
Beta (Volatility)
0.97 (Low)
Price
$24.21
Volume
204
Open
$24.63
Previous Close
$24.21
Daily Range
$23.91 - $24.81
52-Week Range
$9.03 - $28.49
ZYME News
3 Top Biotech Picks for 2025
ZYME: Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Zymeworks
Industry
Biotechnology
Sector
Health CareEmployees
264
CEO
Ken Galbraith
Website
www.zymeworks.comHeadquarters
Middletown, BC V5T 1G4, CA
ZYME Financials
Key Financial Metrics (TTM)
Gross Margin
98%
Operating Margin
-87%
Net Income Margin
-77%
Return on Equity
-27%
Return on Capital
-30%
Return on Assets
-23%
Earnings Yield
-4.46%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$1.80B
Shares Outstanding
74.30M
Volume
204
Short Interest
0.00%
Avg. Volume
753.64K
Financials (TTM)
Gross Profit
$95.17M
Operating Income
$92.55M
EBITDA
$7.65B
Operating Cash Flow
$33.01M
Capital Expenditure
$1.52M
Free Cash Flow
$34.53M
Cash & ST Invst.
$228.80M
Total Debt
$18.27M
Zymeworks Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$2.52M
-91.9%
Gross Profit
$824.00K
-97.3%
Gross Margin
32.76%
N/A
Market Cap
$1.80B
N/A
Market Cap/Employee
$6.01M
N/A
Employees
299
N/A
Net Income
$41.21M
-75.3%
EBITDA
$53.89M
-190.6%
Quarterly Fundamentals
Net Cash
$210.53M
+1.6%
Accounts Receivable
$4.64M
-91.7%
Inventory
$0.00
N/A
Long Term Debt
$14.80M
-6.2%
Short Term Debt
$3.47M
+26.7%
Return on Assets
-23.41%
N/A
Return on Invested Capital
-30.42%
N/A
Free Cash Flow
$10.55M
+74.8%
Operating Cash Flow
$9.98M
+76.0%